Articles

• Biotech on demand

  2012-04-24

  China’s pioneering biopharmaceutical companies – free from traditional constraints – are reinventing biotech manufacturing
  

• Saving lives, saving money

  2012-04-24

  As the global population grows and life expectancy rises, biopharmaceuticals are in ever greater demand for the treatment of life-threatening and chronic diseases. But this class of medicine often comes with a high price tag.
  

• GMP and compliance courses 2012

  2012-02-02

  NNE Pharmaplan is proud to present a new series of GMP and compliance training courses in 2012
  

• Read the latest Angle

  2011-12-08

  Angle is our magazine about health issues and the world around us
  

• Think again...

  2011-11-02

  The time when emerging markets solely acted as the West’s extended production arm is long since gone. Research, ideas and new products increasingly stem from India and China in particular – major countries intent on setting their own agenda.
  

• Emerging markets

  2011-11-02

  THE WORLD UPSIDE DOWN. The term emerging markets is far from new, and like so many other terms its meaning has changed over the years. Today it is synonymous with ever increasing growth – and billions of new, eager consumers.
  

• Practical experience by deployment of MES in the pharmaceutical industry

  2011-10-06

  After years of hesitation the pharmaceutical industry is slowly embracing Manufacturing Execution Systems (MES) as an important mean to gain business benefits.
  

• Winning the MAb race

  2011-10-05

  Next-generation facilities for monoclonal antibody production
  

• Manufacturing systems solution

  2011-09-15

  Manufacturing systems solution - more than manufacturing execution system (MES)
  

• Quality saves lives

  2011-07-01

  Quality assurance of pharmaceuticals is a major public health challenge, particularly in the light of growing cross-border health issues and the international dimensions of trade.
  

• The big misunderstanding

  2011-07-01

  The pharmaceutical industry has not yet started to exploit the full potential of Quality by Design (QbD). The reason: fundamental misunderstandings about the nature of QbD.
  

• SU equipment validation

  2011-05-12

  A systematic and scientific approach for implementation and validation of single-use equipment
  

• Upcoming events

  2011-05-04

  Browse through our events to find out when we will be exhibiting or speaking near you.
  

• Who will make it?

  2011-02-08

  The pharma industry in the next ten years: Who will make it?
  

• We would like your opinion

  2011-02-08

  You are important to us and we would appreciate your help in improving our website. How? Please fill in a very short questionnaire about what you are looking for, what is important to you and what we can do to our website.
  

• Murder by medicine

  2010-11-15

  Counterfeit medicine is a profitable killer. Millions of people die every year and the earnings run into billions of US Dollars.
  

• A new facility concept

  2010-10-07

  From ‘made to order’ to ‘made to configure’. NNE Pharmaplan is investing in preparing modular vaccine facility concepts, designed for vaccine biotypes.
  

• Advanced therapies

  2010-10-07

  Advanced therapies are changing the role of hospitals. Headed by the hospital sector, the evolution of personal therapy systems is occurring at a rapid pace, bringing with it a need for more advanced and flexible facilities.
  

• The ASTM E2500 paradigm

  2010-10-07

  The ASTM E2500 standard presents an alternative to conventional commissioning and qualification practices which, applied effectively, can save money and time while improving quality and increasing focus on patient safety. How much money can you save?
  

• What we do

  2010-09-14

  Focusing on the pharma and biotech industries, NNE Pharmaplan’s mission is to contribute to a healthier world through the services we deliver. Our new offering catalogue "What we do" shows the wealth of consulting and engineering services that we offer.